We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Direct Relationship Found Between Two Antibodies and AD Severity

By LabMedica International staff writers
Posted on 19 Mar 2009
A direct relationship has been discovered between two specific antibodies and the severity of Alzheimer's disease symptoms, raising hopes that a diagnostic blood test for the devastating disorder is within reach.

The body creates antibodies in response to two proteins that are associated with Alzheimer's disease. One protein, known as amyloid-beta, forms the plaques that are evident in the brains of people with Alzheimer's upon autopsy. The other protein, known as RAGE, is involved in the normal aging process but is expressed at higher levels in the brains of people with Alzheimer's.

Scientists from the University of Georgia (Athens, GA, USA), the Charlie Norwood VA Medical Center in Augusta (Augusta, GA, USA), and the Medical College of Georgia (Augusta, GA, USA) compared antibody levels in blood samples from 118 older adults with the participant's level of dementia. The team found that the concentration of two specific proteins that are involved in the immune response increases as the severity of dementia increases.

"We found a strong and consistent relationship between two particular antibodies and the level of impairment," said Professor L. Stephen Miller, director of clinical psychology training in the UGA Franklin College of Arts and Sciences. "The finding brings us closer to our ultimate goal of developing a blood test that can diagnose Alzheimer's disease or potentially identify if someone is at higher risk for the disease."

Related Links:

University of Georgia
Charlie Norwood VA Medical Center in Augusta
Medical College of Georgia




New
Gold Member
Troponin T QC
Troponin T Quality Control
Unit-Dose Packaging solution
HLX
New
Dengue Test
Lab Rapid Dengue NS1
New
Four-in-One Desktop Testing Solution
GULP-1sim/GULP-1ble

Latest Molecular Diagnostics News

Early Blood Test Predicts Survival in Patients with Metastatic Prostate Cancer

POC Sepsis Test Delivers Fast, Accurate and User-Friendly Results in Critical Care Settings

Experimental Blood Test Improves Detection of Early-Stage Pancreatic Cancer